A Possible Cluster of AEFI (Adverse Event Following Vaccination) Following AZD1222 (Covishield) Vaccination in India?

 Abstract

In order to mitigate the spread of the COVID-19 infection in India, the Indian government granted approval for the emergency use of Oxford-AstraZeneca’s COVID-19 (coronavirus disease 2019) vaccine AZD1222 (Covishield). The biggest large-scale COVID-19 vaccination drive in the world is being carried out continuously till date in India. In this research article, a possible cluster of AEFI (Adverse Event Following Vaccination) following AZD1222 (Covishield) vaccination in India has been briefly presented.

Read more about this article: https://juniperpublishers.com/ijoprs/IJOPRS.MS.ID.555676.php

Read more Juniper Publishers Google Scholar Articles: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=Y8LS2LwAAAAJ&citation_for_view=Y8LS2LwAAAAJ:70eg2SAEIzsC

 

Comments

Post a Comment

Popular posts from this blog

Juniper Publishers 2025 Journal Categories Explained: Medicine, Biology, Engineering & More Introduction

  In 2025, multidisciplinary research continues to grow, making journal selection more important than ever. Juniper Publishers is a multidisciplinary open-access publisher offering a broad portfolio of peer-reviewed journals across medicine, life sciences, engineering, physical sciences, social sciences, and emerging interdisciplinary fields. With its expanding journal ecosystem, Juniper Publishers provides researchers, clinicians, and academicians with targeted platforms to publish scholarly work aligned with specific disciplines. This guide explains the major journal categories at Juniper Publishers , helping authors identify suitable publication outlets for their research. For an overview of the publisher’s mission, scope, and structure, authors can refer to the official profile here: 👉 https://juniperpublishers.com/aboutus.php 1. Medical & Clinical Sciences Medical and clinical journals form a core part of the Juniper Publishers portfolio. These journals a...
Read more

A Tracheal Web as a Cause of Dyspnea in a Patient who had been treated for Asthma in the Past 35 years-Juniper Publishers

Image
Juniper Publishers-International Journal of Pulmonary & Respiratory Sciences  A Tracheal Web as a Cause of Dyspnea in a Patient who had been treated for Asthma in the Past 35 years Authored by Strouvalis Ioannis Abstract A Tracheal Web is a soft tissue formation partially occluding the trachea lumen. It is of benign origin and can be either congenital or acquired – the latter mostly in patients with a history of prolonged intubation. Due to the symptoms that are consistent with obstructive lung disease, it can often be misdiagnosed as such. As a result some patients may have been categorized as asthmatics with minimal response to treatment, since the tracheal web causes a fixed obstruction pattern. We describe a case of a female 57 year old patient that had been under asthma treatment for 35 years and was admitted to Sismanogleio Public Hospital, Greece, due to dyspnea consistent with an asthma exacerbation. Keywords: Tracheal web; Asthma; Fiberoptic broncho...
Read more

Inhaledsteroids in COPD? Not in Mybook!

Image
Inhaledsteroids in COPD? Not in Mybook!    Authored by Geertjan Wesseling Chronic Obstructive Pulmonary Disease COPD, is currently the fourth leading cause of death in the world, but projected to be the 3rd leading cause by 2020. More than 3 million people died of COPD in 2012, accounting for 6% of all deaths worldwide. COPD represents an important public health challenge that is both preventable and treatable, if not curable [1]. Characteristically, bronchitis andemphysema are both present in most patients. Smoking cessation is by far the most effective intervention in COPD resulting in better health status, less exacerbations and improved survival [2]. Physical exercise, especially when in the shape of multidisciplinary rehabilitation also has significant effects [3]. To view more Full Text in Juniper Publishers
Read more